Developing new treatments and prevention methods for HIV in children.
Expertise in Professional Pharmaceutical Project Management
This study is all about finding better ways to prevent and treat HIV in kids aged 0-11 by working with experts to create new medicines and strategies that can help them stay healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project ID | NIH-11161812 on NIH RePORTER |
What this research studies
This research focuses on advancing pediatric HIV prevention and treatment by providing essential resources and support for the development of new therapeutic products. It aims to facilitate the discovery and clinical testing of innovative treatments and prevention strategies, particularly for children aged 0-11 years. The approach includes collaboration with academic and private sector partners to ensure that promising candidate products are efficiently developed and brought to clinical trials. By addressing critical gaps in product development, this research seeks to enhance the availability of effective HIV prevention and treatment options for young patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years who are at risk for or affected by HIV/AIDS.
Not a fit: Patients over the age of 11 or those not at risk for HIV/AIDS may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new, effective HIV prevention and treatment options specifically designed for children.
How similar studies have performed: Previous research has shown success in developing pediatric treatments for HIV, indicating a promising avenue for further advancements.
Where this research is happening
Kensington, United States
- Advanced Bioscience Laboratories, INC. — Kensington, United States (Active)
Researchers
- Principal investigator: Silvera, Peter — Advanced Bioscience Laboratories, INC.
- Study coordinator: Silvera, Peter
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.